Skip to content
Wednesday, October 7, 2026
NeonPortal UK

Users Coming Off Weight-Loss Jabs Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

Illustration of medical syringe and scale
Weight management involves ongoing approaches.

Fresh analysis reveals that individuals who stop using blockbuster weight-loss injections like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who stop conventional diet and exercise programs.

Published data in a prominent medical journal shows that while obese people can lose substantial amounts of their total mass while using the jabs, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing such medications must be cognizant of the risk of fast rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery suggests a reversion to starting mass in about one and a half years.

Analyzing Therapies

The analysis, which examined 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with older methods.

Scientists emphasize that individuals who shed pounds through dieting usually see a more gradual weight regain—approximately 100 grams monthly—post-intervention.

The Reason for the Rapid Regain

Doctors believe the way of the injections explains the heightened rebound.

The injections imitate a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Artificially providing the hormone levels several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making overeating a significant risk."

A Lifelong Condition?

Health authorities suggest the injections for individuals with obesity-related health risks, accompanied by prescribed lifestyle changes.

A number of clinicians contend that, given the high risk of relapse, the treatment might need to be ongoing.

This perspective is supported by drug manufacturers, who say that the results "emphasize the persistent character of obesity," comparing it to managing conditions like diabetes.

User Accounts

Individuals who have come off the jabs report a powerful resurgence of cravings.

"It felt as if a switch activating and you're instantly ravenous," recalled one woman.

The struggle is exacerbated if individuals have not adopted lasting lifestyle or habit changes during therapy.

Growing Use

Figures show that millions of adults in the UK have used these injections in the past year, with desire being substantial.

  • Use is greater among women than men.
  • The 40s and 50s age group shows the greatest level of interest.
  • Many obtain the medications through private prescriptions rather than public health services.

In conclusion, experts stress that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle support.

JM
Written by

Jill Montgomery

A tech enthusiast and digital strategist with over a decade of experience in emerging technologies and content creation.

NeonPortal UK

Type to search articles.